Prevalence, morphology, and prognosis of human papillomavirus in tonsillar cancer

Annals of Otology, Rhinology and Laryngology

Volumn 118, Issue 10, 2009, Pages 742-749

  Luginbuhl, Adam ^a   Sanders, Melinda ^b   Spiro, Jeffrey D ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Human papillomavirus; Tonsillar cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER STAGING; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INCIDENCE; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TONSIL CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PALATINE TONSIL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TONSILLAR NEOPLASMS;

EID: 70350512134     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940911801010     Document Type: Article

References (39)

1. Tonsillar cancer epidemiology. Hartford, Conn: Department of Health, State of Connecticut, 2006.
2. Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 2000;11:489-495 (Pubitemid 30342838)
3. Murdock JM, Gluckman JL. African-American and white head and neck carcinoma patients in a university medical center setting. Are treatments provided and are outcomes similar or disparate? Cancer 2001;91:279-283
4. Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 2007;86:104-114
5. Wilczynski SP, Lin BT, Xie Y, Paz IB. Detection of human papillomavirus DnA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squa mous cell carcinoma. Am J Pathol 1998;152:145-156 (Pubitemid 28028055)
6. Andl T, Kahn T, Pfuhl A, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 1998;58:5-13. (Pubitemid 28027707)
7. Münger K, Werness BA, Dyson n, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989;8:4099-4105
8. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-1136 (Pubitemid 120035062)
9. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002;21:1510-1517 (Pubitemid 34226138)
10. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. nat Rev Cancer 2002;2:342-350
11. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. nature 1996;380:79-82.
12. Hafkamp HC, Manni JJ, Speel EJ. Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol 2004;124:520-526 (Pubitemid 38797618)
13. Guo M, Gong Y, Deavers M, et al. Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DnA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma. J Clin Microbiol 2008;46:274-280
14. Hafkamp H, Mooren J, Claessen S. P21cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol 2009;22:686-698
15. Chung YL, Lee MY, Horng CF, et al. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiotherapy alone. Head neck 2009;31:9-20.
16. Dahlgren L, Mellin H, Wangsa D, et al. Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer 2003;107:244-249 (Pubitemid 37152904)
17. Mellin H, Friesland S, Auer G, Dalianis T, Munck-Wikland E. Human papillomavirus and DnA ploidy in tonsillar cancer - correlation to prognosis. Anticancer Res 2003;23:2821-2828 (Pubitemid 36969819)
18. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001;92:805-813 (Pubitemid 32783066)
19. Bristow RG, Benchimol S, Hill RP. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 1996;40:197-223. (Pubitemid 27314227)
20. Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006;24:5630-5636 (Pubitemid 46631302)
21. Charfi L, Jouffroy T, de Cremoux P, et al. Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett 2008;260:72-78
22. Chien CY, Su CY, Fang FM, et al. Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol 2008;44:174-179
23. Kim SH, Koo BS, Kang S, et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 2007;120:1418-1425 (Pubitemid 46355375)
24. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006;31:259-266 (Pubitemid 44141088)
25. Smith EM, Wang D, Kim Y, et al. p16 InK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol 2008;44:133-142 (Pubitemid 351179656)
26. Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 2000;60:396-402. (Pubitemid 30127310)
27. Hobbs CG, Groves E, Davenport V, et al. Tonsil T cell immunity to human papillomavirus in the absence of detectable virus in healthy adults. Laryngoscope 2008;118:459-463 (Pubitemid 351640617)
28. Foote RL, Schild SE, Thompson WM, et al. Tonsil cancer. Patterns of failure after surgery alone and surgery combined with postoperative radiation therapy. Cancer 1994;73:2638-2647
29. Syrjänen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004;57:449-455
30. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J natl Cancer Inst 2000;92:709-720
31. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DnA in tonsillar carcinomas. Cancer 2001;92:2875-2884 (Pubitemid 33091923)
32. Haraf DJ, nodzenski E, Brachman D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996;2:755-762
33. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999;109:1544-1551 (Pubitemid 29477216)
34. Pintos J, Franco EL, Black MJ, Bergeron J, Arella M. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer 1999;85:1903-1909 (Pubitemid 29202762)
35. Riethdorf S, Friedrich RE, Ostwald C, et al. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 1997;26:315-321 (Pubitemid 27309067)
36. Strome SE, Savva A, Brissett AE, et al. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 2002;8:1093-1100 (Pubitemid 35177361)
37. Spiro JD, Spiro RH. Carcinoma of the tonsillar fossa. An update. Arch Otolaryngol Head neck Surg 1989;115:1186-1189
38. Worden F, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated HPV16 copy number. J Clin Oncol 2008;26:3138-3146
39. Albers A, Abe K, Hunt J, et al. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res 2005;65:11146-11155 (Pubitemid 41713386)